Recovery & Repair
BPC-157 5mg
5MG · lyophilized
Order & shipping details
Quantity breaks: 5 = −10% · 10 = −15%. Bulk pricing at qty ≥ 10.
- Typically ships the same business day — orders before 3:00 PM PST
- Discreet packaging — nothing on the outside
- Arrived damaged? Contact support — we'll help
What this is
A synthetic 15-amino-acid peptide. BPC stands for Body Protection Compound — based on a partial sequence of a protein found in gastric juice.
That origin story is genuinely the interesting part. BPC-157 is not a naturally occurring molecule you can isolate; it is a synthetic sequence derived from a stretch of a larger protein identified in gastric juice. Researchers took the fragment, not the whole protein, which is a pattern you will see repeatedly in this catalog — isolate the region of interest, drop the rest.
Fifteen amino acids makes it a short peptide by any measure, and short peptides are comparatively straightforward to synthesise and to verify. That is part of why BPC-157 has accumulated such a large research literature: it is accessible, it is cheap to make well, and it is easy to characterise. It is also why purity verification actually means something here — a 15-mer either resolves as one clean HPLC peak or it does not.
This is the 5mg vial. The 10mg vial is the same compound at higher mass, and it has a published certificate for its current lot.
Research profile
One of the most-cited peptides in tissue-repair research. Studied in preclinical and in-vitro models of angiogenesis and connective-tissue signaling. Not an approved drug. Research use only.
Two words in that sentence do a lot of work and are worth unpacking.
Preclinical means the published work sits in cell culture and animal models. It has not moved into the regulatory pathway that would make it a medicine, and we are not going to imply that it has.
Model means the compound is being used as a tool to study a pathway, not as a candidate therapy. Most BPC-157 literature is investigating how angiogenic and connective-tissue signaling behave — the peptide is the probe, not the product.
Research suggests BPC-157 remains one of the more heavily-worked compounds in that space, which is a statement about publication volume, not about efficacy. High citation count means there is a lot to read; it does not mean the questions are settled. Anyone telling you otherwise about this compound is ahead of the evidence.
BPC-157 also appears more than any other single compound in blend formulations — it is in our BPC-157 + TB500 blend, the GHK-Cu + BPC-157 + TB-500 70mg blend and the KLOW 80mg blend. That reflects how often it is co-studied with TB-500 in the tissue-repair literature.
Specifications
| Property | This lot |
|---|---|
| Compound | BPC-157 (Body Protection Compound-157) |
| CAS | 137525-51-0 |
| Sequence length | 15 amino acids |
| Labelled mass | 5mg |
| Reported chromatographic purity | 99.8 Area%, HPLC-UV/VIS |
| Certificate status | Available on request for this lot |
| Physical form | Lyophilized powder |
| Storage (unopened) | −20°C |
| Reconstitution | Bacteriostatic water — see the reference calculator on this page |
Lab testing and this lot's certificate
Every lot in the catalog is tested by Vanguard Laboratory, an independent A2LA-accredited lab (A2LA certificate #6377.01.01) in Olympia, Washington — chromatographic purity by HPLC-UV/VIS, quantity by assay, and endotoxin by LAL.
The 5mg vial's current lot has no published certificate yet. We would rather say that plainly than let a badge imply a document that is not on the page. Email support and we will send whatever exists for the lot you have, or check the lab tests page where certificates go as they are published.
If you want a BPC-157 lot whose certificate is already published and downloadable, the 10mg vial currently carries one — Laboratory ID V260407-4 023, 11.68mg assay, <5.00 EU/mg endotoxin, purity >99.80 Area%.
That transparency is the entire point of how we sell. The certificate is the product. When one is not on the page yet, saying so is more useful to you than a green tick.
Handling and storage
Lyophilized. Reconstitute with bacteriostatic water; store the powder at minus 20C.
Sealed and lyophilized, BPC-157 is one of the more forgiving compounds in the catalog — the freeze-dried powder tolerates shipping at ambient temperature without issue. The care starts once you reconstitute. Solution is a working preparation; the powder is the stock.
The reconstitution reference on this page converts diluent volume into resulting concentration. It is a reference for in-vitro laboratory handling only. Its outputs describe the physical properties of the reconstituted vial — concentration and mass drawn — and are not dosing guidance, administration instructions, or medical advice.
Bacteriostatic water is sold separately, and the 10ml is free with your first subscription order.
Questions
Is the certificate for this lot published?
Not yet — for the current 5mg lot it is available on request. The 10mg vial's current lot does have a published certificate. Anything published lives on the lab tests page.
What does "99.8 Area%" actually mean?
It is the proportion of the total chromatogram area under the main peak in an HPLC-UV/VIS run. Practically: 99.8% of what the detector saw was the target compound. Our internal threshold treats anything at or above 98.0 Area% as a pass.
What is the difference between the 5mg and 10mg vials?
Mass, and — right now — certificate status. Same compound, same testing regime, same storage.
Why does BPC-157 appear in so many of your blends?
Because it is co-studied with TB-500 more often than with anything else in the tissue-repair literature, and because it is one of the most-requested compounds in the catalog. That combination shows up in three of our blend SKUs.
Should the powder be refrigerated during shipping?
No. Lyophilized peptide is stable in transit at ambient temperature. Put it at −20°C when it arrives.
Research Use Only. This product is sold for in-vitro research use only. It is not a drug, not a supplement, and not for human or veterinary use. Hello Stacks makes no claims regarding the safety, efficacy or suitability of any compound for any use, and publishes no dosing guidance.